| 000 | 00946 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517075335.0 | ||
| 264 | 0 | _c20160824 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a2213-1787 | ||
| 024 | 7 |
_a10.1016/j.jchf.2015.12.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlather, Marcus D | |
| 245 | 0 | 0 |
_aUnderstanding Mechanisms of Action of Beta-Blockers in Heart Failure With Reduced and Preserved Ejection Fraction. _h[electronic resource] |
| 260 |
_bJACC. Heart failure _cFeb 2016 |
||
| 300 |
_a150-151 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aStroke Volume |
| 700 | 1 | _aGollop, Nicholas D | |
| 773 | 0 |
_tJACC. Heart failure _gvol. 4 _gno. 2 _gp. 150-151 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jchf.2015.12.009 _zAvailable from publisher's website |
| 999 |
_c25681102 _d25681102 |
||